Home Events Human Leukocyte Antigen (hla) Testing In Allogeneic Hematopoietic Stem Cell Transplantation

Human Leukocyte Antigen (hla) Testing In Allogeneic Hematopoietic Stem Cell Transplantation

Date

May 06 2021

Time

12:30 pm - 1:15 pm

Speaker

  • Dr. Robert Liwski Dr. Robert Liwski
    Dr. Robert Liwski
    Dr. Robert Liwski

    Dr. Robert Liwski is the Head of the Division on Hematological Pathology, Medical Director of the HLA Laboratory and Professor of Pathology at the Queen Elizabeth II Health Sciences Centre / Dalhousie University in Halifax, Canada. He is also the Medical and Scientific Director of the HLA Laboratory at the Canadian Blood Services Head Office in Ottawa.

    His research interests include transplantation immunology and optimization of diagnostic testing in transplantation. Dr. Liwski has developed several optimized HLA antibody testing procedures including the Halifax/Halifaster flow crossmatch protocols. He was awarded the Canadian Association of Pathologists Junior Scientist Award for his research investigating the role of activated protein C in prevention of ischemia reperfusion injury and cancer metastasis.

Description

The lecture will provide an overview of HLA typing and HLA antibody testing techniques and how the histocompatibility information is used to select donors for allogeneic stem cell transplantation.

Objectives

  • At the end of this session, participants will be able to list hematopoietic stem cell sources used in transplantation
  • At the end of this session, participants will be able to describe the role of HLA matching in hematopoietic stem cell transplantation.
  • At the end of this session, participants will be able to list molecular techniques used for high resolution HLA typing.
  • At the end of this session, participants will be able to describe the importance of HLA antibody testing in donor selection

Register